It is well known that liposomes are used as drug carriers: examples are antitumor agents, hormones, and immunomodulation. 1, 2) On the other hand, we have recently produced specific hybrid liposomes composed of vesicular and micellar molecules; they are stable for a longer period. The physical properties of these liposomes such as size, membrane fluidity, phase transition temperature, and hydrophobicity can be controlled by changing the constituents and compositional ratios of hybrid liposomes. 3, 4) In the course of our study on hybrid liposomes, the following interesting results were obtained. (a) Stereochemical control of the enantioselective hydrolysis of amino acid esters could be established by temperature regulation and by changing the composition of hybrid liposomes. 9) (d) No toxicity of the hybrid liposomes was observed in normal cells in vitro nor in normal rats in vivo. 8, 10) In this study, we report on hybrid liposomes composed of L-a -dimyristoylphosphatidylcholine (DMPC) and polyoxyethylenedodecyl ether (C 12 (EO) n : CH 3 (CH 2 ) 11 O(CH 2 CH 2 O) n H) having inhibitory effects on the growth of human breast tumor cells (MDA-MB-453) in vitro along with apoptosis.
In the course of our study on hybrid liposomes, the following interesting results were obtained. (a) Stereochemical control of the enantioselective hydrolysis of amino acid esters could be established by temperature regulation and by changing the composition of hybrid liposomes. [3] [4] [5] (b) Inhibitory effects of hybrid liposomes including flavonoids 6) or antitumor drugs 7, 8) on the growth of tumor cells in vitro and in vivo have been obtained. (c) High inhibitory effects on the growth of glioma cells in vitro using three-component hybrid liposomes containing sugar surfactants have been obtained without drugs.
9) (d) No toxicity of the hybrid liposomes was observed in normal cells in vitro nor in normal rats in vivo. 8, 10) In this study, we report on hybrid liposomes composed of L-a -dimyristoylphosphatidylcholine (DMPC) and polyoxyethylenedodecyl ether (C 12 (EO) n : CH 3 (CH 2 ) 11 O(CH 2 CH 2 O) n H) having inhibitory effects on the growth of human breast tumor cells (MDA-MB-453) in vitro along with apoptosis.
Hybrid liposomes were prepared by sonication (VELVO VS-N300, 300W) of a mixture containing 95 mol% DMPC and 5 mol% C 12 (EO) n in 5% glucose solution at 45°C with 300W, followed by filtration with a 0.20 mm filter.
First, we examined the fifty percent inhibitory concentration (IC 50 ) of hybrid liposomes (HL-n) on the growth of MDA-MB-453 cells in vitro on the basis of WST-1 assay.
11)
The tumor cells (5.0ϫ10 4 viable cells/ml) were cultured for 48 h in an incubator at 37°C after adding the sample solutions. WST-1 solutions were added and the absorbance at wavelength of 450 nm was measured by spectrophotometer. The inhibitory concentration was evaluated by A mean / A control , where A mean and A control denote the absorbance of water-soluble formazan, which was useful as an indicator of cell viability, in the presence and absence of sample solutions, respectively. The results are shown in Fig. 1 . The IC 50 values of HL-n were from one seventh to a half of those of the DMPC liposomes, indicating that the inhibitory effects of hybrid liposomes are large when compared with those of the DMPC liposomes.
Morphology of hybrid liposomes (HL-n) was examined on the basis of dynamic light scattering measurements. Hydrodynamic diameter (d hy ) of HL-n was 80-120 (HL-21 and 23) and 90-110 nm (HL-25), which remained stable for more than three weeks. On the other hand, it was found that DMPC liposomes, HL-4 and HL-10 were unstable. It is worthy to note that HL-n (nϭ21, 23, 25) having a diameter of 100 nm could avoid the clearance by reticular endothelial system in vivo.
12)
Second, we examined the mechanism for inhibiting the growth of MDA-MB-453 cells in vitro. Fluorescence micrographs of MDA-MB-453 cells using TUNEL method after the treatment with hybrid liposomes are shown in Fig. 2 . The green color (FITC) was observed in the cells after adding hybrid liposomes, although the green color of cells was not observed in the case of DMPC liposomes. These results showed that hybrid liposomes can induce apoptosis for MDA-MB-453 cells. Apoptotic DNA rates for MDA-MB-453 cells treated with hybrid liposomes are shown in Fig. 3 . HL-23 was most effective for increasing apoptotic DNA rates among all the liposomes employed in this study. On the other hand, a little apoptotic DNA rate was obtained for DMPC liposomes and C 12 (EO) n micelles. So, we next examined caspase cascade in relation to apoptosis induced by HL-23 on the basis of caspase fluorometric protease assay. It is well known that the apoptosis signal is transduced by sequential activation of caspase family cystein protease. The results are shown in Fig. 4 . Activation of caspase-3, -8 and -9 was observed for MDA-MB-453 cells after the treatment with HL-23, indicating that these hybrid liposomes could induce apoptosis through the activation of caspase-3, -8 and -9. The In conclusion, the induction of apoptosis for MDA-MB-453 cells after the treatment with hybrid liposomes was clarified on the basis of TUNEL method and flow cytometric analysis. It is worthy to note that the highly apoptotic DNA rate through the activation of caspases for MDA-MB-453 cells treated with the hybrid liposomes (HL-23) was obtained for the first time. [DMPC]ϭ0.45 mM, [C 12 (EO) n ]ϭ0.024 mM TUNEL assay was performed using an in situ cell death detection kit (Roche Diagnostics GmbH) with a confocal laser microscope (TCS, Leica). 
